Beauty Industry

Johnson & Johnson Reports Sales Increase in First Quarter of 2021

Listerine and Johnson’s Baby perform well in the Consumer Health category.

Johnson & Johnson has shared results for first-quarter 2021. 
 
Reported sales for the quarter were $22,321 million, up 7.9% compared to 2020.
 
Consumer Health worldwide operational sales, excluding the net impact of acquisitions and divestitures, declined 2.9% primarily driven by negative prior year comparisons related to the Covid-19 pantry loading in Q1 2020, mainly in over-the counter products. Partially offsetting the decline is growth in Listerine in oral care products and Johnson’s Baby in baby care products, international skin health/beauty products.
 
“The ability to deliver these results while simultaneously advancing our robust pipeline of life-enhancing medicines, products and solutions during these times is a testament to the strength and resilience of our business and the dedication of the 135,000 employees of Johnson & Johnson who strive every day to profoundly change the trajectory of health for humanity and make healthier communities for everyone, everywhere,” said Alex Gorsky, chairman and CEO.

Add us as a preferred source on Google

Get the latest Beauty Packaging news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Beauty Packaging Newsletters